Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -8739.34% is 642% below its 5-year average of -1178.33%, around the middle of its 5-year range (-24486.27%–0.00%).
38.36% above its 12-month average of -14177.27%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -8079.11%.
OPERATING MARGIN
-8739.34%
OPERATING MARGIN AVG TTM
-14177.27%
OPERATING MARGIN AVG 3Y
-5168.80%
OPERATING MARGIN AVG 5Y
-1178.33%
OPERATING MARGIN AVG 10Y
-571.31%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+38.36%
CURRENT VS 3Y AVG
-69.08%
CURRENT VS 5Y AVG
-641.67%
CURRENT VS 10Y AVG
-1429.69%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dianthus Therapeutics, Inc.
Market Cap
$4.92B
Operating Margin
-8739.34%
TTM Avg
-14177.27%
3Y Avg
-5168.80%
5Y Avg
-1178.33%
Market Cap
$5.02B
Operating Margin
10.90%
TTM Avg
-12.82%
3Y Avg
-40.85%
5Y Avg
-40.85%
Market Cap
$4.81B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.78B
Operating Margin
-20.62%
TTM Avg
-55.73%
3Y Avg
-88.20%
5Y Avg
-107.26%
Market Cap
$5.20B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
Market Cap
$5.20B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.27B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.92B | -8739.34% | -14177.27% | -5168.80% | -1178.33% |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 10.90% | -12.82% | -40.85% | -40.85% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -20.62% | -55.73% | -88.20% | -107.26% |
| Erasca, Inc. (ERAS)vs › | $5.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 0.00% | 0.00% | -101.20% | -276.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 12.75% | 11.82% | 10.28% | 7.77% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 0.00% | 0.00% | 0.00% | -174.05% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -34.31% | -42.52% | -56.23% | -56.23% |
Gross Margin
96.0%
Operating Margin
-8739.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -8079.11% |
| 2026-03-31 | -10050.32% |
| 2025-12-31 | -24486.27% |
| 2025-09-30 | -10173.74% |
| 2025-06-30 | -18096.89% |
| 2025-03-31 | -2852.71% |
| 2024-12-31 | -2406.94% |
| 2024-09-30 | -1376.61% |
| 2024-06-30 | -1191.84% |
| 2024-03-31 | -2041.65% |
| 2023-12-31 | -2835.01% |
| 2023-09-30 | -1705.52% |
| 2023-06-30 | -1215.27% |
| 2023-03-31 | -1614.08% |
| 2022-12-31 | -910.04% |
| 2022-09-30 | -703.67% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
